Home / Research library / Pramiracetam Powder
Pramiracetam Powder: molecular data, studies & sources
Pramiracetam Powder is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C14H27N3O2
- Molecular weight (MW)
- 269.38 g/mol
- PubChem compound ID
- 51712
- Record title
- Pramiracetam
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 51712 · retrieved 2026-09-21
Chemical identifiers and source data
- IUPAC name
- N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
- InChIKey
- ZULJGOSFKWFVRX-UHFFFAOYSA-N
- SMILES
- CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C
Identifiers
- PubChem CID
- 51712
- CAS Registry Number
- 68497-62-1via ChemIDplus, EPA DSSTox, FDA GSRS
- FDA UNII
- 4449F8I3LE
- ChEMBL ID
- CHEMBL159776
- InChIKey
- ZULJGOSFKWFVRX-UHFFFAOYSA-N
- Wikidata
- Q415746
Other names and development codes: CI-879 FREE BASE
CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 269.2103 Da |
|---|---|
| Heavy atoms | 19 |
| Hydrogen-bond donors | 1 |
| Hydrogen-bond acceptors | 3 |
| Rotatable bonds | 7 |
| Topological polar surface area | 52.7 Ų |
| Calculated logP (Crippen) | 0.84 |
| Rings | 1 |
| Stereocenters | 0 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
US regulatory status & drug development
Drug development record (ChEMBL)
Harmonized drug-development record from ChEMBL. The highest clinical stage is the furthest stage reached, as recorded by ChEMBL; it can lag regulatory approvals, and it is not an approval of a research-supplier product.
- ChEMBL ID
- CHEMBL159776
- Modality
- Small molecule
- Highest clinical stage
- Phase 2
- Record name
- PRAMIRACETAM
Synonyms, codes and trade names
- Synonyms and development codes
- CI-879 FREE BASE · Pramiracetam
Identity check: Identical standard InChIKey to the PubChem record. Source: ChEMBL CHEMBL159776 (EMBL-EBI, CC BY-SA 3.0) · retrieved 2026-10-07
Registered clinical trials
Studies registered on ClinicalTrials.gov that list Pramiracetam as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
1 registered study matched.
- By highest phase
- Phase 1 · 1
- By registry status
- Completed · 1
| Study | Phase · status | Conditions | Sponsor · size |
|---|---|---|---|
| Reliability of Standardized IQ Testing Under Modafinil, Racetam-Class Compounds, Sleep Restriction and Daily ActivityNCT07852130 · start 2026-03-09 · primary completion 2026-09-09 | Phase 1Completed | Healthy · Cognition · Sleep Deprivation | Abdulraheem Mohamed Gouda70 participants |
Registry check 2026-10-09 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received Pramiracetam, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
- Human study · PubMed trial index Compound given to participants
Pharmacokinetics of oral pramiracetam in normal volunteers.
Chang T, Young RM, Goulet JR et al. · Journal of clinical pharmacology · 1985
PMID 4008675 · DOI: 10.1002/j.1552-4604.1985.tb02841.x
- Human study · PubMed trial index Compound given to participants
Placebo-controlled study of pramiracetam in young males with memory and cognitive problems resulting from head injury and anoxia.
McLean A, Cardenas DD, Burgess D et al. · Brain injury · 1991
PMID 1786500 · DOI: 10.3109/02699059109008110
- Human study · PubMed trial index Compound given to participants
Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam.
Claus JJ, Ludwig C, Mohr E et al. · Neurology · 1991
PMID 2011259 · DOI: 10.1212/wnl.41.4.570
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Preclinical / laboratory research
[Pharmacokinetics of pramiracetam in animals].
Fang Z, Liu X, Xiao Y et al. · Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao · 1999
PMID 11387954
Pramiracetam Powder supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Pramiracetam Powder for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 10000mg Powder1 recorded offers | 10000mg Powder · $30.00Checked Nov 6, 2026Supplier listing, Pramiracetam Powder 10000mg Powder, Amino USA, opens in a new tab |
Reference sources & further reading
- PubChem compound record 51712 — chemical identity and structure.
- ChEMBL drug record CHEMBL159776 — development stage, mechanism and synonyms.
- FDA Global Substance Registration System: UNII 4449F8I3LE — substance identity, names and codes.
- Wikipedia: Pramiracetam — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Adalank Spray
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human intervention studies
Adamax
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human intervention studies
Adamax 1032 Spray
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human intervention studies
Agomelatine Powder
C15H17NO2
243.30 g/mol · PubChem CID 82148
8 selected publications · 5 human intervention studies · 19 registered trials
Small molecule · highest stage: Approved in at least one jurisdiction (ChEMBL phase 4)
Cerebrolysin
Molecular identity needs further verification
7 selected publications · 5 human intervention studies · 40 registered trials
Dihexa
C27H44N4O5
504.7 g/mol · PubChem CID 129010512
2 selected publications · 0 human intervention studies